Atlas Trials

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Clinical trial NCT06116890 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06116890
Sponsor
Kyowa Kirin Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neovascular Age-Related Macular Degeneration (nAMD)
Start date
2024-01-31
Primary completion
2026-08-31
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.